A citation-based method for searching scientific literature

Susan M Domchek, Tara M Friebel, Susan L Neuhausen, Theresa Wagner, Gareth Evans, Claudine Isaacs, Judy E Garber, Mary B Daly, Rosalind Eeles, Ellen Matloff, Gail E Tomlinson, Laura Van't Veer, Henry T Lynch, Olufunmilayo I Olopade, Barbara L Weber, Timothy R Rebbeck. Lancet Oncol 2006
Times Cited: 210



Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff, Mary B Daly, Olufunmilayo I Olopade, Barbara L Weber. J Clin Oncol 2004
Times Cited: 697




List of shared articles



Times cited

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Mary B Daly, Tuya Pal, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L Hutton,[...]. J Natl Compr Canc Netw 2021
27

Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops.
Manjusha Hurry, Anthony Eccleston, Matthew Dyer, Paul Hoskins. Int J Technol Assess Health Care 2020
2

Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.
Thomas B Silverman, Alejandro Vanegas, Awilda Marte, Jennie Mata, Margaret Sin, Juan Carlos Rodriguez Ramirez, Wei-Yann Tsai, Katherine D Crew, Rita Kukafka. BMC Health Serv Res 2018
6

Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
George U Eleje, Ahizechukwu C Eke, Ifeanyichukwu U Ezebialu, Joseph I Ikechebelu, Emmanuel O Ugwu, Onyinye O Okonkwo. Cochrane Database Syst Rev 2018
28

A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.
Anthony Eccleston, Anthony Bentley, Matthew Dyer, Ann Strydom, Wim Vereecken, Angela George, Nazneen Rahman. Value Health 2017
31

Surgical Decision Making in the BRCA-Positive Population: Institutional Experience and Comparison with Recent Literature.
Teresa Flippo-Morton, Kendall Walsh, Karinn Chambers, Lisa Amacker-North, Brook White, Terry Sarantou, Danielle M Boselli, Richard L White. Breast J 2016
16

The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
Lynn C Hartmann, Noralane M Lindor. N Engl J Med 2016
145

Managing patients at genetic risk of breast cancer.
Holly J Pederson, Shilpa A Padia, Maureen May, Stephen Grobmyer. Cleve Clin J Med 2016
4

Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review.
Xiao Li, Ran You, Xinwei Wang, Congxin Liu, Zicheng Xu, Jin Zhou, Bin Yu, Ting Xu, Hongzhou Cai, Qing Zou. Clin Cancer Res 2016
63

Mathematical models of breast and ovarian cancers.
Dana-Adriana Botesteanu, Stanley Lipkowitz, Jung-Min Lee, Doron Levy. Wiley Interdiscip Rev Syst Biol Med 2016
4


Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers.
Elizabeth A Schackmann, Diego F Munoz, Meredith A Mills, Sylvia K Plevritis, Allison W Kurian. Fam Cancer 2013
8